1. Home
  2. ENSC vs ZDAI Comparison

ENSC vs ZDAI Comparison

Compare ENSC & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.39

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

ZDAI

Primega Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.12

Market Cap

9.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
ENSC
ZDAI
Founded
2003
2022
Country
United States
Hong Kong
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
General Bldg Contractors - Nonresidential Bldgs
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
9.6M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
ENSC
ZDAI
Price
$0.39
$1.12
Analyst Decision
Analyst Count
0
0
Target Price
★ $5.13
N/A
AVG Volume (30 Days)
★ 535.6K
4.5K
Earning Date
11-13-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.24
N/A
EPS
N/A
★ N/A
Revenue
★ $5,066,650.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.23
$0.20
52 Week High
$2.17
$11.48

Technical Indicators

Market Signals
Indicator
ENSC
ZDAI
Relative Strength Index (RSI) 36.37 44.30
Support Level $0.39 $0.40
Resistance Level $0.44 $1.77
Average True Range (ATR) 0.05 0.10
MACD -0.01 0.00
Stochastic Oscillator 2.44 46.95

Price Performance

Historical Comparison
ENSC
ZDAI

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About ZDAI Primega Group Holdings Limited Ordinary Shares

DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: